Where does Constellation Pharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Constellation Pharmaceuticals, Inc. ranks #6,230 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Constellation Pharmaceuticals, Inc. hold?

Constellation Pharmaceuticals, Inc. holds 54 US utility patents granted between 2015 and 2024, spanning 9 technology areas.

What is Constellation Pharmaceuticals, Inc.'s Innovation Score?

Constellation Pharmaceuticals, Inc. has an Innovation Score of 36.6 out of 100 (top 46% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Constellation Pharmaceuticals, Inc. focus on?

Constellation Pharmaceuticals, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 50 patents, ranking #355 of 6,058 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Constellation Pharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

Constellation Pharmaceuticals, Inc.'s recent grant velocity is -58% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Constellation Pharmaceuticals, Inc.'s patents?

Constellation Pharmaceuticals, Inc.'s patents average 15.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Constellation Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Constellation Pharmaceuticals, Inc.

USPTO PatentsView assignee record - 54 granted patents across 9 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Constellation ranks #6,230 of 49,997 tracked US assignees by granted-patent volume, with 54 patents across 9 technology areas.

#6,230
of 49,997 US assignees by volume: Top 46%
by Innovation Score (36.6/100): 15.5
avg claims per patent: -58%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6230 · US Corporation #6,230 · 54 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 54 grants
UPPER-Q #6,230/49,997
PHOTO-FINISH Cenovus Energy
CPC-NARROW A61P · 9 areas
INNOV-THIN 36.6/100
CLAIMS-RICH 15.5 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -58% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Cenovus Energy Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Constellation’s 36.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.8 pts (38%) Velocity 2.9 pts (8%) Breadth 10.6 pts (29%) Claim depth 9.3 pts (25%)

Qualcomm Incorporated · highest

85
Beijing Apollo Ding… · near

37
Constellation… · this assignee

37
Lumenis · near

37
Omega Ophthalmics · near

37
Relx · near

37
3D Lighting… · lowest

7

What this shows Constellation's Innovation Score is 36.6/100 (top 46% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Constellation?

Each dot is one of Constellation’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Constellation’s own 15.5 claims/patent is ABOVE the 12.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Constellation vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Constellation's grants concentrate

Constellation Pharmaceuticals, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 92.6% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (14 grants) versus a trough of 1 in 2023. By volume, Constellation sits between Cenovus Energy Inc. and Distech Controls Inc..

Constellation's three-year grant acceleration

From 2019–2021 to 2022–2024, Constellation Pharmaceuticals, Inc. moved from 21 to 9 grants (0.43x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Cenovus Energy

54
Clarkson Universi…

54
Classic Brands

54
Comau S p A

54
Dai-ichi Kogyo Se…

54
DAS

54
Debiotech

54
Distech Controls

54
Constellation Pha… ◀

54

What this shows Constellation holds 54 patents at rank #6,230, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Constellation

By rank, the assignees closest to #6,230 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Constellation's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Constellation, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Constellation ranks #355 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (37 here).

Lumenis Ltd. 37 Omega Ophthalmics LLC 37 Beijing Apollo Ding Rong Solar Technology Co., Ltd. 37 Relx Inc. 37

Similar claim depth

Nearest assignees by average claims per patent (15.5 here).

University of Cincinnati 15.5 avg Ovid Therapeutics Inc. 15.5 avg The University of Western Australia 15.5 avg Fermi Research Alliance, LLC 15.5 avg

Constellation's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 46% higher than 54% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Constellation Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	5.6%
2016	9	16.7%
2017	3	5.6%
2018	9	16.7%
2019	14	25.9%
2020	4	7.4%
2021	3	5.6%
2022	5	9.3%
2023	1	1.9%
2024	3	5.6%

Which technologies does Constellation Pharmaceuticals, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 50

C07D - Heterocyclic Compounds 50

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 34

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 2

C07C - Acyclic OR Carbocyclic Compounds 2

Y02A - Technologies FOR Adaptation TO Climate Change 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

C07K - Peptides 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Constellation Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

Constellation Pharmaceuticals, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 92.6% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #6,230 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Constellation Pharmaceuticals, Inc. against Cenovus Energy Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.